China and Hong Kong stocks rise after new reports of easing COVID restrictions Economic slowdown fears temper risk sentiment Gas prices rise as freezing weather blankets Europe LONDON, Dec 8 (Reuters) – Global equities and oil prices battled their way out of a four-day slump on Thursday as deeply inverted bond yield curves and choppy …
Stocks and oil struggle to emerge from four-day drop Read More »
Vietnam to hold first large-scale arms fair this week The country’s nascent military industry plans to export for the first time He seeks faster diversification of Russian military supplies HANOI, Dec 7 (Reuters) – Vietnam is considering a major defense shift as it seeks to reduce its dependence on Russian weapons and launch a drive …
Analysis: Vietnam shifts gears on arms trade as it loosens ties with Russia Read More »
WASHINGTON, Dec 6 (Reuters) – When U.S. officials first floated the idea of capping Russian oil export prices in response to a planned European embargo in March, they pledged to cut revenue of the Russian war machine, while avoiding a devastating spike in oil prices. But keeping Russian oil on the market and global prices …
Analysis: Russia’s G7 oil price ceiling moves from revenue squeeze to market anchor Read More »
LONDON, Dec 5 (Reuters) – Pension funds and other “non-bank” financial firms hold more than $80 trillion in hidden off-balance sheet dollar debt in foreign exchange swaps, the Bank for International Settlements (BIS) said. ). The BIS, dubbed the central bank of central banks around the world, also said in its latest quarterly report that …
Currency swap debt is an $80 trillion global regulator, says ‘blind spot’ Read More »
NEW DELHI, Nov 29 (Reuters) – Moscow has sent India a list of more than 500 deliverables, including parts for cars, planes and trains, four sources familiar with the matter said, as sanctions reduce Russia’s ability to keep its vital industries running. . The list, a version of which was seen by Reuters in New …
Exclusive: India asked sanction-hit Russia for parts for key sectors Read More »
Trials show small benefit, but without statistical validity Roche setback leaves Biogen and Eisai as leaders in the field It’s up to Roche’s CEO-designate to revive development fortunes Roche shares down 3.4%, its development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) Alzheimer’s drug candidate has not been shown to slow the progression …
Roche’s Alzheimer’s drug fails in long-awaited trial Read More »
